Eosinophils play a crucial role in bronchial asthma. As theophylline and procaterol (β
2-agonist) are used for the treatment of bronchial asthma, the specific functions of eosinophils in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) or platelet activating factor (PAF) were examined using theophylline and procaterol alone and in combination. Eosinophil degranulation induced by PAF or GM-CSF was inhibited by theophylline (10
-6 M-10
-3 M and 10
-6 M to 10
-3 M, respectively) and procaterol (10
-7 M-10
-5 M and 10
-7 M-10
-5 M, respectively). The combination of 10
-4 M theophylline and various concentrations of procaterol provided higher inhibition than 10
-4 M theophylline or procaterol (10
-7 M-10
-5 M). CD11b, which is a triggering molecule for human eosinophil degranulation, showed a significantly inhibited expression of PAF stimulation with 10
-4 M theophylline. CD11b and another triggering molecule for eosinophil degranulation, CD18, showed a significantly inhibited expression of PAF stimulation using a combination of 10
-4 M theophylline and various concentrations of procaterol (10
-5 M-10
-7 M) compared with the inhibition of 10
-4 M theophylline or procaterol (10
-5 M-10
-7 M), but GM-CSF-stimulated eosinophils were not inhibited. Taken collectively, theophylline and/or procaterol have anti-inflammatory effects.
(Internal Medicine 36: 276-282, 1997)
抄録全体を表示